Dengue virus (DENV) is the most important mosquito-borne disease in humans. Approximately 2.5 billion people worldwide live in areas with a risk of dengue transmission, and it is estimated that 50 million dengue infections occur annually (1) (2) . In Minas Gerais, Brazil (Figure 1) , 21,105cases were reported in 2012, and more than 350,000 cases were reported in 2013 (1,750 cases/100,000 habitants) (3) .
Different DENV serotypes (1, 2, 3, 4) are usually associated with systemic and dynamic diseases, with clinical illness ranging from a nonspecifi c viral syndrome (dengue fever with or without warning signs) to severe disease (severe dengue). Dengue is classifi ed as severe when the disease progresses to severe plasma leakage, hemorrhage, and organ (e.g., CNS) impairment (2) . Among the plethora of clinical symptoms caused by DENV, neurological manifestations are often misdiagnosed or neglected. During dengue epidemics in Brazil, public health organizations and clinics are typically overloaded, and within this context, some atypical or rare dengue clinical manifestations are not properly diagnosed (2) (4) .
Phylogenetic studies have classifi ed DENV-3 into fi ve genotypes (I, II, III, IV, and V) based on their genetic diversity (5) . Our laboratory has isolated and characterized DENV-3 genotype I from patients and mosquitoes in different cities of Minas Gerais (Figure 1 ), most recently (2013) in Contagem, MG (unpublished data) (6) (7) . The patients presented with a wide range of clinical manifestations including headache, light sensitivity, retro-orbital pain, general body pain (arthralgia, myalgia), vomiting, and hemorrhage (6) . In addition, previous studies have demonstrated an important feature of DENV-3 genotype I, which is its ability to cause CNS infection and modulate the immunological system in a mouse model that was intracranially inoculated (8) (9) .Neurological manifestations of dengue infection in humans range from a common headache to more severe symptoms, such as nuchal rigidity, reduced consciousness, and convulsions. Moreover, some cases can experience severe encephalopathy, which can lead to sequelae (10) .
CASE REPORT
Our laboratory was contacted by a local hospital to diagnose a 21-year-old patient in October 2012. On October 1, she presented with the onset of dengue symptoms, including fever, myalgia, and general malaise. On October 7, the hospital emergency department attended the patient, who presented with generalized seizures, and released her on the same day. On October 9, the patient presented with another episode of seizures and was admitted to the hospital to be treated with an anticonvulsant. An episode of seizures occurred on the following day, and an electroencephalogram revealed irritation in the frontal region of the brain. The last episode of seizures was described on October 13, when the patient received intensive care at the hospital and cerebrospinal fl uid (CSF) was collected. The results revealed the presence of leukocytes (7 cells/mL), glucose levels in the CSF of 78g/L, and protein levels of 36g/L. Aiming to characterize the etiological agent, the patient's CSF was sent to our laboratory. RNA was extracted (Viral RNA QIAamp Extraction Kit; Qiagen, Valencia, USA), followed by reverse transcription using random primers (MMLV; Promega, Madison, USA). The cDNA was used as the template in the quantitative PCR (qPCR) with primers designed to amplify the NS5 region of the viruses from the genus Flavivirus (11) . qPCR was performed with a commercial mix (SYBR® Green 
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Contagem Belo Horizonte Caratinga PCR Master Mix, Life Technologies, Carlsbad, USA), and specifi c amplifi cation with a melting temperature of 79.5°C was observed. The primers used for amplifi cation were forward,5´-GTGTCCCAGCCGGCGGTGTCATCAGC-3´, and reverse, 5´-TACAACATGATGGGAAAGCGAGAGAAAAA-3´( 11) . PCR failed to detect HSV-1, HSV-2, VZV, CMV, and viruses of the genus Enterovirus.
To identify the Flavivirus that was the etiological agent of this infection, a specific PCR for DENV was performed, targeting the C-prM region (forward, 5´-TCAATATGCTGAAACGCGCGAGAAACCG-3´, and reverse, 5´-TTGCACCAACAGTCAATGTCTTCAGGTTC-3´) (12) . Amplifi cation of a 511-bpDNA fragment was observed, confi rming 
DISCUSSION
Although data concerning the role of viral agents in CNS infections have increased in recent years, DENV has not been DENV as the etiological agent. Both PCR tests were performed in duplicate, with two different samples to confi rm the diagnosis. The amplifi ed DNA fragment was directly sequenced in both directions using a Mega-BACE-sequencer (GE Healthcare; Little Chalfont, UK) (13) .The optimal alignment of the C-prM region using ClustalW (www.ncbi.nlm.nih.gov/pmc/articles/PMC308517) and MEGA version 5 (www.megasoftware.net) showed high identity among the nucleotide sequence of the sample (GenBank accession number 1735167) and other DENV-3 sequences deposited in GenBank. The paired nucleotide identity between our sample and other DENV-3 sequences ranged from 93.8% to 98.2% (14) . Phylogenetic trees of the C-prM region were constructed using the neighbor-joining and maximum parsimony methods with 1,000 bootstrap replicates and the Kimura 2-parameter model (14) . Both models showed that the DNA fragment sequence clustered with other sequences of DENV-3genotype I from Brazil, Asia, and Central America (Figure 3) . The nucleotide identity ranged from 97.1% to 98.2% when comparing pairwise our sample with other genotype I sequences. The study followed the rules of the Ethics Committee of Universidade Federal de Minas Gerais (Number 2129.0.000.410-10).
included in diagnostic assays because it is not considered a classical neuropathogenic virus (2) (10) (15) . The most frequently described neurological symptom associated with dengue is mental confusion, which is often interpreted as a consequence of high fever. CNS DENV-3 infections have been described in humans and are also reproducible in animal models (9) (15) .
Our report describes a DENV infection in the CNS caused by DENV-3 genotype I, which has also been detected in human cases and mosquitos (Figure 1) (6) (7) (8) . As DENV-3 genotype I was detected in different years in the same city (Belo Horizonte: 2002 , 2003 ,and 2004 , this genotype has been circulating in this region since that time (6) . Our previous studies demonstrated that DENV-3 genotype I had neurovirulent potential in a murine model (8) . We have now confirmed the presence of DENV-3 genotype I in the CSF of a patient with generalized seizures and behavioral changes, emphasizing the importance of this genotype to public health in Minas Gerais (3) . Because DENV infections in the CNS and the associated neurological manifestations are possibly misdiagnosed in Brazil (e.g., meningoencephalitis and encephalitis), this report serves as an alert regarding the importance of DENV diagnosis in CNS infections. Furthermore, because this viral pathogen is not identifi ed in most cases of CNS viral infection in Brazil, the number of cases and impact on public health might be more important than suspected, and the number of dengue infections in the CNS might be underestimated (2) (10) . Finally, this study provides new information regarding the symptoms and signs of dengue infection in the CNS with neurological manifestations and an update to the DENV-3 genotype I epidemiology in Brazil.
